PathAI will exclusively work with Roche Tissue Diagnostics (RTD) to develop artificial intelligence (AI) digital pathology algorithms for RTD s companion.
By Mauro Orru Roche Holding entered into an agreement with PathAI to leverage artificial intelligence for the development of algorithms in companion diagnostics, tests used to help match.
/PRNewswire/ The "In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028".
Roche Tissue Diagnostics employs about 9,900 people across the U.S. and in 2021, its 10 locations conducted about 27 billion diagnostic tests globally.
In its annual celebration of outstanding community champions who volunteer their time, talent and resources to build a thriving community, United Way of Tucson and Southern Arizona selected and honored